350 related articles for article (PubMed ID: 7759783)
1. Development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake.
Kristensen HL; Vadstrup S; Knudsen N; Siersbaek-Nielsen K
J Endocrinol Invest; 1995 Jan; 18(1):41-3. PubMed ID: 7759783
[TBL] [Abstract][Full Text] [Related]
2. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.
Rieu M; Bekka S; Sambor B; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1993 Jul; 39(1):67-71. PubMed ID: 8348708
[TBL] [Abstract][Full Text] [Related]
4. Transient thyrotoxicosis in endemic goitre patients following exposure to a normal iodine intake.
Lima N; Medeiros-Neto G
Clin Endocrinol (Oxf); 1984 Dec; 21(6):631-7. PubMed ID: 6439440
[TBL] [Abstract][Full Text] [Related]
5. Preclinical hyperthyroidism in multinodular goiter.
Gemsenjäger E; Staub JJ; Girard J; Heitz P
J Clin Endocrinol Metab; 1976 Oct; 43(4):810-6. PubMed ID: 61970
[TBL] [Abstract][Full Text] [Related]
6. The lack of nocturnal serum thyrotropin surge in patients with nontoxic nodular goiter may predict the subsequent occurrence of hyperthyroidism.
Bartalena L; Martino E; Velluzzi F; Piga M; Petrini L; Loviselli A; Grasso L; Pinchera A
J Clin Endocrinol Metab; 1991 Sep; 73(3):604-8. PubMed ID: 1874936
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormones homeostasis and TSH in autonomic thyroid nodule.
Negoescu I; Simescu M; Constantinescu A
Endocrinologie; 1978; 16(2):111-6. PubMed ID: 79214
[TBL] [Abstract][Full Text] [Related]
8. Transient lack of thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in treated hyperthyroid patients with normal or low serum thyroxine (T4) and triiodothyronine (T3).
Sanchez-Franco F; García MD; Cacicedo L; Martin-Zurro A; Escobar del Ray F; Morreale de Escobar G
J Clin Endocrinol Metab; 1974 Jun; 38(6):1098-102. PubMed ID: 4208806
[No Abstract] [Full Text] [Related]
9. Selective pituitary resistance to thyroid hormone after treatment of a toxic multinodular goiter.
Vesely DL
South Med J; 1988 Sep; 81(9):1173-6. PubMed ID: 3420449
[TBL] [Abstract][Full Text] [Related]
10. [Hyperthyroidism in the thyroid hormone treatment of iodine deficiency goiter].
Emrich D; Klaushenke G
Dtsch Med Wochenschr; 1986 Apr; 111(15):577-81. PubMed ID: 3082613
[TBL] [Abstract][Full Text] [Related]
11. TSH secretion and regulation in endemic goiter and endemic cretinism.
Medeiros-Neto G
Prog Clin Biol Res; 1983; 116():119-30. PubMed ID: 6304776
[TBL] [Abstract][Full Text] [Related]
12. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.
Huysmans DA; Nieuwlaat WA; Erdtsieck RJ; Schellekens AP; Bus JW; Bravenboer B; Hermus AR
J Clin Endocrinol Metab; 2000 Oct; 85(10):3592-6. PubMed ID: 11061507
[TBL] [Abstract][Full Text] [Related]
13. The natural history of euthyroid multinodular goitre.
Elte JW; Bussemaker JK; Haak A
Postgrad Med J; 1990 Mar; 66(773):186-90. PubMed ID: 2114018
[TBL] [Abstract][Full Text] [Related]
14. Relapses of hyperthyroidism in patients treated with radioiodine for nodular toxic goiter: relation to thyroid autoimmunity.
Custro N; Ganci A; Scafidi V
J Endocrinol Invest; 2003 Feb; 26(2):106-10. PubMed ID: 12739735
[TBL] [Abstract][Full Text] [Related]
15. [Proceedings: Kinetics and disposal rate of triiodothyronine in patients with atuonomous hot nodular goiter, with or without thyrotoxicosis (author's transl)].
Mirouze J; Jaffiol C; Baldet L; Robin M; Radjohnson L
Ann Endocrinol (Paris); 1975; 36(3):173-4. PubMed ID: 1190731
[TBL] [Abstract][Full Text] [Related]
16. Serum thyrotrophin and response to thyrotrophin-releasing hormone in patients who are euthyroid after radioiodine treatment for hyperthyroidism.
Gordin A; Wägar G; Hernberg A
Acta Med Scand; 1973 Oct; 194(4):335-40. PubMed ID: 4127154
[No Abstract] [Full Text] [Related]
17. Increased serum thyroglobulin concentrations and impaired thyrotropin response to thyrotropin-releasing hormone in euthyroid subjects with endemic goiter in Sicily: their relation to goiter size and nodularity.
Vermiglio F; Benvenga S; Melluso R; Catalfamo S; Princi P; Battiato S; Consolo F; Trimarchi F
J Endocrinol Invest; 1986 Oct; 9(5):389-96. PubMed ID: 3098822
[TBL] [Abstract][Full Text] [Related]
18. Thyroid nodule producing T3 toxicosis in a child.
Popma BH; Cloutier MD; Hayles AB
Mayo Clin Proc; 1973 Apr; 48(4):273-5. PubMed ID: 4632731
[No Abstract] [Full Text] [Related]
19. The incidence of hyperthyroidism in patients with thyroid cancer in an area of iodine deficiency.
Gulcelik MA; Gulcelik NE; Dinc S; Kuru B; Camlibel M; Alagol H
J Surg Oncol; 2006 Jul; 94(1):35-9. PubMed ID: 16788941
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and management of the autonomously functioning thyroid nodule: the Walter Reed Army Medical Center experience, 1975-1996.
Burch HB; Shakir F; Fitzsimmons TR; Jaques DP; Shriver CD
Thyroid; 1998 Oct; 8(10):871-80. PubMed ID: 9827653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
